Wiezorek Jeffrey

SVP Clinical Development at Kite Pharma, Inc.

Sold, on record
$10M
Dollars the filings state
Form 4 sales
24
Latest Sep 25, 2017
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Kite Pharma, Inc.Plan not stated
    Nov 10, 2016 2016

    Sold 1,500 shares at $50.18 ($75k)

    Wiezorek Jeffrey, SVP Clinical Development

    Sold 8.7% of holdings ($869k position)15,811 shares left0.2x usual sizeFiling

  2. 2 Form 4 sale Kite Pharma, Inc.Plan not stated
    Dec 1, 2016 +21 days

    Sold 1,500 shares at $50.76 ($76k)

    Wiezorek Jeffrey, SVP Clinical Development

    Sold 8.7% of holdings ($879k position)15,811 shares left0.2x usual sizeFiling

  3. 3 Form 4 sale Kite Pharma, Inc.Plan not stated
    Dec 20, 2016 +19 days

    Sold 716 shares at $50.86 ($36k)

    Wiezorek Jeffrey, SVP Clinical Development

    Sold 4.5% of holdings ($804k position)15,095 shares left0.1x usual sizeFiling

  4. 4 Form 4 sale Kite Pharma, Inc.Plan not stated
    Jan 6, 2017 +17 days

    Sold 1,500 shares at $50.00 ($75k)

    Wiezorek Jeffrey, SVP Clinical Development

    Sold 6.8% of holdings ($1.1M position)20,695 shares left0.2x usual sizeFiling

  5. 5 Form 4 sale Kite Pharma, Inc.Plan not stated
    Feb 1, 2017 +26 days

    Sold 1,500 shares at $51.21 ($77k)

    Wiezorek Jeffrey, SVP Clinical Development

    Sold 6.8% of holdings ($1.1M position)20,695 shares left0.2x usual sizeFiling

  6. 6 Form 4 sale Kite Pharma, Inc.Unusual
    Mar 1, 2017 +28 days

    Sold 18,000 shares at $75.01 ($1.4M)

    Wiezorek Jeffrey, SVP Clinical Development

    Sold 46.1% of holdings ($2.9M position)21,071 shares left2x usual sizeFiling

  7. 7 Form 4 sale Kite Pharma, Inc.Unusual
    Jul 3, 2017 +124 days

    Sold 10,000 shares at $104.32 ($1M)

    Wiezorek Jeffrey, SVP Clinical Development

    Sold 32.2% of holdings ($3.2M position)21,071 shares left1.7x usual sizeFiling

  8. 8 Form 4 sale Kite Pharma, Inc.Plan not stated
    Sep 25, 2017 +84 days

    Sold 5,283 shares at $179.66 ($949k)

    Wiezorek Jeffrey, SVP Clinical Development

    Sold 17% of holdings ($5.6M position)25,824 shares left2.3x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (24)

Form 144 notices and Form 4 sales by Wiezorek Jeffrey
Source
Sep 25, 2017Sep 27, 2017Kite Pharma, Inc.SVP Clinical DevelopmentForm 4 sale5,283$949k17.0%Plan not statedSEC
Jul 3, 2017Jul 6, 2017Kite Pharma, Inc.SVP Clinical DevelopmentForm 4 sale10,000$1M32.2%UnusualSEC
Mar 1, 2017Mar 2, 2017Kite Pharma, Inc.SVP Clinical DevelopmentForm 4 sale18,000$1.4M46.1%UnusualSEC
Feb 1, 2017Feb 6, 2017Kite Pharma, Inc.SVP Clinical DevelopmentForm 4 sale1,500$77k6.8%Plan not statedSEC
Jan 6, 2017Jan 10, 2017Kite Pharma, Inc.SVP Clinical DevelopmentForm 4 sale1,500$75k6.8%Plan not statedSEC
Dec 20, 2016Dec 22, 2016Kite Pharma, Inc.SVP Clinical DevelopmentForm 4 sale716$36k4.5%Plan not statedSEC
Dec 1, 2016Dec 5, 2016Kite Pharma, Inc.SVP Clinical DevelopmentForm 4 sale1,500$76k8.7%Plan not statedSEC
Nov 10, 2016Nov 14, 2016Kite Pharma, Inc.SVP Clinical DevelopmentForm 4 sale1,500$75k8.7%Plan not statedSEC
Oct 3, 2016Oct 5, 2016Kite Pharma, Inc.SVP Clinical DevelopmentForm 4 sale1,500$82k8.7%Plan not statedSEC
Sep 1, 2016Sep 2, 2016Kite Pharma, Inc.SVP Clinical DevelopmentForm 4 sale1,500$87k8.7%Plan not statedSEC
Aug 1, 2016Aug 2, 2016Kite Pharma, Inc.SVP Clinical DevelopmentForm 4 sale1,500$85k9.2%Plan not statedSEC
Jul 1, 2016Jul 5, 2016Kite Pharma, Inc.SVP Clinical DevelopmentForm 4 sale1,500$75k9.2%Plan not statedSEC
Jun 1, 2016Jun 2, 2016Kite Pharma, Inc.SVP Clinical DevelopmentForm 4 sale3,000$152k16.8%Plan not statedSEC
Mar 15, 2016Mar 17, 2016Kite Pharma, Inc.SVP Clinical DevelopmentForm 4 sale9,000$404k37.7%UnusualSEC
Feb 16, 2016Feb 18, 2016Kite Pharma, Inc.SVP Clinical DevelopmentForm 4 sale9,000$397k39.6%UnusualSEC
Jan 15, 2016Jan 19, 2016Kite Pharma, Inc.SVP Clinical DevelopmentForm 4 sale9,000$497k39.6%UnusualSEC
Dec 15, 2015Dec 17, 2015Kite Pharma, Inc.SVP Clinical DevelopmentForm 4 sale9,000$574k58.7%UnusualSEC
Nov 16, 2015Nov 18, 2015Kite Pharma, Inc.SVP Clinical DevelopmentForm 4 sale9,000$703k58.7%UnusualSEC
Oct 15, 2015Oct 19, 2015Kite Pharma, Inc.SVP Clinical DevelopmentForm 4 sale9,000$563k58.7%UnusualSEC
Sep 15, 2015Sep 17, 2015Kite Pharma, Inc.VP Clinical DevelopmentForm 4 sale9,000$579k58.7%UnusualSEC
Aug 17, 2015Aug 19, 2015Kite Pharma, Inc.VP Clinical DevelopmentForm 4 sale9,000$548k63.3%UnusualSEC
Jul 15, 2015Jul 20, 2015Kite Pharma, Inc.VP Clinical DevelopmentForm 4 sale9,000$647k63.3%UnusualSEC
Jun 15, 2015Jun 17, 2015Kite Pharma, Inc.VP Clinical DevelopmentForm 4 sale9,000$513k63.3%UnusualSEC
May 15, 2015May 19, 2015Kite Pharma, Inc.VP Clinical DevelopmentForm 4 sale9,000$451k88.1%UnusualSEC